Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000202782 | SCV000202214 | likely benign | not specified | 2015-10-28 | criteria provided, single submitter | clinical testing | |
Genomic Diagnostic Laboratory, |
RCV000202782 | SCV000257697 | likely benign | not specified | 2015-06-25 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000202782 | SCV000593550 | likely benign | not specified | 2017-04-12 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000640853 | SCV000762454 | benign | Alpha thalassemia-X-linked intellectual disability syndrome | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001706009 | SCV001870635 | benign | not provided | 2019-02-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002426727 | SCV002731369 | benign | Inborn genetic diseases | 2018-04-24 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002505160 | SCV002809577 | likely benign | Acquired hemoglobin H disease; Alpha thalassemia-X-linked intellectual disability syndrome; Intellectual disability-hypotonic facies syndrome, X-linked, 1 | 2022-03-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001706009 | SCV004165895 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | ATRX: BS2 |
Prevention |
RCV004544390 | SCV004770696 | likely benign | ATRX-related disorder | 2021-03-05 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |